Extendicare (TSE:EXE) Releases Earnings Results
by Scott Moore · The Cerbat GemExtendicare (TSE:EXE – Get Free Report) released its earnings results on Thursday. The company reported C$0.42 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of C$465.22 million for the quarter. Extendicare had a return on equity of 47.65% and a net margin of 5.82%.
Extendicare Stock Performance
Shares of TSE:EXE traded up C$0.03 during trading on Thursday, reaching C$30.20. 272,384 shares of the stock were exchanged, compared to its average volume of 308,029. Extendicare has a 12 month low of C$12.12 and a 12 month high of C$30.81. The firm has a market cap of C$2.85 billion, a PE ratio of 27.13 and a beta of 1.27. The stock has a 50-day moving average price of C$27.50 and a 200-day moving average price of C$23.30. The company has a current ratio of 1.37, a quick ratio of 0.98 and a debt-to-equity ratio of 91.85.
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, May 15th will be issued a dividend of $0.0441 per share. This represents a c) dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Thursday, April 30th. Extendicare’s payout ratio is currently 44.92%.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on EXE. TD Securities raised Extendicare from a “hold” rating to a “buy” rating and lifted their target price for the company from C$19.00 to C$32.00 in a research report on Monday, April 6th. Canadian Imperial Bank of Commerce lifted their price target on Extendicare from C$22.00 to C$32.00 in a report on Thursday, April 2nd. Desjardins set a C$34.50 price target on Extendicare and gave the stock a “buy” rating in a report on Wednesday, April 22nd. BMO Capital Markets lifted their price target on Extendicare from C$24.00 to C$30.00 in a report on Monday, March 2nd. Finally, National Bank Financial lifted their price target on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating and five have assigned a Buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of C$29.38.
Get Our Latest Stock Report on EXE
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.